Everand Logo

Welcome to Everand!

  • Discover millions of ebooks, audiobooks, and so much more with a free trial

    Only $11.99/month after trial. Cancel anytime.

    Eu Gmp Annex 13 (Investigational Medicinal Products , Complexity Meets Reality)
    Eu Gmp Annex 13 (Investigational Medicinal Products , Complexity Meets Reality)
    Eu Gmp Annex 13 (Investigational Medicinal Products , Complexity Meets Reality)
    Audiobook1 hour

    Eu Gmp Annex 13 (Investigational Medicinal Products , Complexity Meets Reality)

    Written by Rango Dietrich

    Narrated by Rango Dietrich, Alison Rippier and Joseph Rippier

    ()

    About this audiobook

    Get to know more about the scope and limits of complex regulatory guidelines! PharmAudio audiobook Understanding Pharma Guidelines EU GMP ANNEX 13 Investigational Medicinal Products Complexity Meets Reality Read by Alison Rippier, Dr Joseph Rippier and Dr Rango Dietrich Implementing pharmaceutical regulatory guidelines is a complex matter. Reading these regulatory procedures, understanding them and putting them into practice not only requires time but often also assistance—and here it is: the current regulatory guidelines as an audiobook with qualified comments based on long years of industrial and consulting experience. The requirements stipulated by GMP (Good Manufacturing Practice) for the preparation of investigational medicinal products are regulated in Annex 13. Many interfaces to GCP (Good Clinical Practice), the QP (Qualified Person) and to the entire supply chain have to be translated professionally into real processes. Dr Rango Dietrich provides comments on the most important texts, drawing on over twenty years of experience, to make the texts easier for the listener to understand.

    LanguageEnglish
    PublisherPharmaudio Guidelines
    Release dateMar 14, 2014
    Eu Gmp Annex 13 (Investigational Medicinal Products , Complexity Meets Reality)

    Related to Eu Gmp Annex 13 (Investigational Medicinal Products , Complexity Meets Reality)

    Related audiobooks

    Science & Mathematics For You

    View More
    View More

    Related podcast episodes

    Related articles

    • Article

      Indian Pharma's Big Leap

      Apr 30, 2018

      Indian Pharma's Big Leap
      6 min read

    • Article

      EPA’s New PFAS Definition Will Make it Harder to Protect the Public

      Aug 22, 2023

      The agency's new plan for "forever chemicals" could allow thousands of types of them to escape regulation.

      4 min read

    • Article

      Standard Operating Procedures In Cannabis Production

      Jul 22, 2022

      In cannabis production, standard operating procedures (SOPs) form the backbone of operations and compliance, especially when it comes to medical cannabis cultivation. SOPs are essentially a set of best practices and standards that detail the daily op

      2 min read

    • Article

      Health, Hash, and Happiness

      Oct 31, 2023

      Most people are introduced to cannabis in the form of flower. It’s approachable — easy to smoke, easy to find, and affordable. It may take time before a cannabis connoisseur dabbles with concentrates. Even those paid to understand the products, like

      1 min read

    • Article

      Opinion: U.S. Biologics And Biosimilars Need Distinguishable Names

      Apr 23, 2019

      Creating distinguishable nonproprietary names for biologics and their biosimilars will help ensure that patients get the right medications and will be useful for identifying adverse events more readily.

      5 min read

    • Article

      EPA Strengthens Emissions Controls for Facilities Emitting Cancer-Causing Ethylene Oxide

      Mar 18, 2024

      Last week, the US Environmental Protection Agency (EPA) finalized updated regulations for certain facilities that emit ethylene oxide (EtO), a colorless, cancer-causing gas. These long-awaited rules will require facilities using EtO to sterilize medi

      5 min read

    • Article

      Opinion: ‘One-and-done’ For New Drugs Could Cut Patent Thickets And Boost Generic Competition

      Feb 11, 2019

      Instead of patenting new drugs, companies are recycling old ones to build insurmountable patent walls. We can fix that with a "one-and-done" approach that gives each drug one, and only…

      4 min read

    • Article

      Opinion: FDA Is Smashing The Status Quo For Regulatory Science

      Oct 14, 2019

      The FDA can enable innovation by being a partner in advancing new approaches to drug development and regulatory science. Its recent reorganization signals a revolutionary shift in regulatory velocity.

      5 min read

    • Article

      Tested and True

      Mar 10, 2023

      Tested and True
      2 min read

    • Article

      Opinion: Real-world Data Can Help Make Better Drugs And Do It Faster

      May 2, 2018

      Relying solely on clinical trials to demonstrate the safety and effectiveness of new drugs can be risky. Real-world data can help.

      4 min read

    • Article

      Time Is Of The Essence

      Apr 30, 2022

      As we emerge, somewhat tentatively, out of a bruising pandemic, humanity continues to struggle with myriad challenges brought about by a continued focus on short-term, narrow-thinking models and paradigms, which have regrettably paved the way for uns

      2 min read

    • Article

      Opinion: A Quantum Of Innovation And The Incentives To Match

      Mar 7, 2019

      Modest tweaks to drugs, what some dismiss as "merely incremental," can represent real and compelling advances for patients and offer great value over time.

      9 min read

    • Article

      Consumer Reporting

      Sep 27, 2019

      Consumer Reporting
      2 min read

    • Article

      Pioneering a New Landscape

      Nov 30, 2020

      Pioneering a New Landscape
      2 min read

    • Article

      Your vitamin BOOST

      Jul 29, 2017

      Your vitamin BOOST
      5 min read

    • Article

      No Easy Cure

      Dec 11, 2017

      No Easy Cure
      6 min read

    • Article

      Your Voice Is Needed as EPA Updates its Rule on Risk Management of Chemical Facilities

      Mar 18, 2022

      UCS Research Director Jacob Carter calls on all public health experts and those living near at-risk chemical facilities to weigh in on changes the EPA will make to its Risk Management Plan rule. The public comment period is scheduled to begin Septemb

      2 min read

    • Article

      Delivering Pain Relief

      May 30, 2018

      With the growing popularity and understanding of the medicinal properties of cannabis, David Sutton, president of NanoSphere, decided to apply his pharmaceutical knowledge to the industry. The result was NanoSerum, a transdermal cannabinoid-based pai

      1 min read

    • Article

      Opinion: Realizing The Promise Of Prescription Digital Therapeutics

      Oct 29, 2019

      Prescription digital therapeutics will be a key piece of the emerging global digital market, which may be worth more than half a trillion dollars by 2025.

      3 min read

    Related categories

    Reviews for Eu Gmp Annex 13 (Investigational Medicinal Products , Complexity Meets Reality)

    0 ratings

    0 ratings0 reviews

    What did you think?

    Tap to rate

    Review must be at least 10 words